Betamethazone

Reading File

Finding Sources

Searching PubMed

betamethasone clinical uses pharmacology

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive information to provide a detailed answer. Let me compile everything.

Betamethasone

Betamethasone is a potent, long-acting synthetic glucocorticoid derived from prednisolone, with high anti-inflammatory activity and minimal (negligible) mineralocorticoid effect. The "meta" prefix refers to the position of the fluorine and methyl substituents on the steroid nucleus (C16-beta methyl, C9-alpha fluoro).

Drug Class & Structure

Betamethasone belongs to the glucocorticoid class of corticosteroids. Key structural features:

C9-alpha fluorine (increases potency and metabolic resistance)
C16-beta methyl group (distinguishes it from dexamethasone, which has C16-alpha methyl)
Halogenated and C16-methylated molecule - classified in Group 2 (non-methylated backbone derivatives) in dermatology potency systems

Available as several esters/salts with different pharmacokinetics:

Betamethasone sodium phosphate - soluble, rapid onset (IV/IM)
Betamethasone acetate - sparingly soluble, depot (IM, intra-articular)
Betamethasone dipropionate - topical, super/high potency
Betamethasone valerate - topical, mid-high potency

Mechanism of Action

Betamethasone acts via the glucocorticoid receptor (GR) - a nuclear transcription factor:

Binding: Free betamethasone enters cells and binds intracellular GR, causing a conformational change and release from chaperone complex (HSP90)
Nuclear translocation: The ligand-GR complex translocates to the nucleus
Transactivation: GR homodimers bind glucocorticoid response elements (GRE) in DNA and recruit coregulators that increase transcription of anti-inflammatory genes (e.g., IkB, the inhibitory subunit of NF-kB; lipocortin/annexin A1)
Transrepression: GR monomers tether to AP-1 or NF-kB at DNA and suppress transcription of proinflammatory genes including:
- IL-2, IL-6, TNF-alpha
- COX-2 (reduces prostaglandin synthesis)
- Inducible nitric oxide synthase
- Collagenase

This dual genomic mechanism results in broad immunosuppression and anti-inflammation. Non-genomic effects (rapid membrane-level actions) also contribute at high doses.

Goodman & Gilman's Pharmacological Basis of Therapeutics, p. 1029

Potency Comparisons

Betamethasone has approximately 25-30x the anti-inflammatory potency of hydrocortisone with essentially no mineralocorticoid activity.

Steroid	Anti-inflammatory Potency (relative)	Mineralocorticoid Activity
Hydrocortisone	1	1
Prednisone	4	0.8
Dexamethasone	25-30	0
Betamethasone	25-30	0

Because of negligible mineralocorticoid activity, betamethasone cannot be used alone for adrenocortical insufficiency - it must be combined with a mineralocorticoid (e.g., fludrocortisone).

Harriet Lane Handbook, 23rd ed., p. 1038

Formulations & Dosing

Injectable (Celestone Soluspan)

Suspension: 6 mg/mL (3 mg/mL betamethasone sodium phosphate + 3 mg/mL betamethasone acetate)
For IM, intra-articular, intrasynovial, intralesional, and soft-tissue injection only - NOT for IV use

Anti-inflammatory (systemic):

Child: 0.0175-0.125 mg/kg/24 hr or 0.5-7.5 mg/m²/24 hr Q6-12h IM
Adolescent/Adult: 0.6-9 mg/24 hr divided Q12-24h IM

Topical

Dipropionate 0.05% (cream, ointment, lotion, emulsion) - Class 1-2 super/high potency (Diprolene)
Valerate 0.1% (cream, ointment, foam, lotion) - Class 3-5 upper mid to lower mid potency
Augmented dipropionate 0.05% (Diprolene) - Super potency Class 1

Apply once to twice daily; maximum 2 weeks for augmented forms; max 50 g cream/ointment or 50 mL lotion per week.

Augmented dipropionate (Diprolene) not recommended in children ≤12 years due to high risk of adrenal suppression.

Harriet Lane Handbook, 23rd ed.; Goldman-Cecil Medicine

Key Clinical Indications

1. Antenatal Fetal Lung Maturation (most important obstetric use)

Regimen: Two doses of 12 mg IM (combination: 6 mg betamethasone acetate + 6 mg betamethasone sodium phosphate) given 24 hours apart

Stimulates surfactant production and structural maturation of fetal lungs
Reduces: RDS, IVH, NEC, perinatal mortality, need for ventilator support, surfactant use
Recommended at <34 weeks for threatened preterm delivery within 7 days
Late preterm (34-36 6/7 weeks): A single course is now also recommended for women who have not received prior antenatal steroids and are at high risk of delivery in this period (MFMU ALPS trial showed significant reduction in neonatal respiratory complications: RR 0.67, 95% CI 0.53-0.84)
Betamethasone and dexamethasone are the only steroids proven beneficial for this purpose (others like prednisolone have poor placental transfer)
Rescue course may be considered if initial dose was >7 days prior and GA <32 6/7 weeks; multiple courses (>2) are not recommended
Creasy & Resnik's Maternal-Fetal Medicine, p. 899-900

2. Dermatological Conditions (topical)

High-potency betamethasone is used for:

Psoriasis
Atopic and contact dermatitis
Lichen planus, lichen simplex chronicus
Scalp conditions (valerate foam - Luxiq)
Nummular eczema, other steroid-responsive dermatoses
Fitzpatrick's Dermatology; Goldman-Cecil Medicine

3. Inflammatory and Rheumatologic Conditions

Intra-articular: inflammatory arthritis, bursitis, tendinitis
Soft tissue: trigger finger, carpal tunnel, etc.
Systemic anti-inflammatory in allergic, autoimmune, and inflammatory states

4. Other uses

Spinal cord compression (parenteral)
Posterior uveitis
Cerebral edema management
Keloids (intralesional)

Adverse Effects

Like all glucocorticoids, betamethasone can cause:

Metabolic/Endocrine:

Hyperglycemia, insulin resistance
Adrenal axis suppression (especially with prolonged use or potent topical preparations)
Cushing syndrome (iatrogenic) with chronic high doses
Osteoporosis, avascular necrosis

Cardiovascular:

Hypertension (though minimal mineralocorticoid effects)
Sodium and water retention at high doses

Neurological:

Pseudotumor cerebri
Mood changes, psychosis

GI:

GI bleeding, peptic ulceration (especially with NSAIDs)

Skin (topical):

Skin atrophy, telangiectasia, striae
Acne, perioral dermatitis
Tachyphylaxis with prolonged use

Ophthalmologic:

Cataracts (posterior subcapsular)
Glaucoma

Infections:

Increased susceptibility to bacterial, fungal, viral infections (systemic use)
Harriet Lane Handbook, 23rd ed., p. 1038

Drug Interactions

Betamethasone is a CYP3A4 substrate: strong CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir) increase betamethasone exposure and risk of side effects
NSAIDs + corticosteroids: increased GI bleeding risk
Antidiabetics: may need dose adjustment due to hyperglycemia
Live vaccines: contraindicated during systemic corticosteroid therapy

Special Considerations

Caution in: hypothyroidism (prolonged effect), cirrhosis (reduced metabolism), ulcerative colitis, history of corticosteroid allergy
Pregnancy: Category C/D - systemic betamethasone crosses the placenta (this is intentional in the antenatal lung maturation indication)
Breastfeeding: Caution advised; may suppress neonatal adrenal function
Topical in children: Use lowest potency formulation; monitor for HPA axis suppression; augmented dipropionate contraindicated in children ≤12 years

Summary

Betamethasone is a highly potent, mineralocorticoid-sparing glucocorticoid available in injectable, topical, and intralesional forms. Its most critical clinical role is antenatal corticosteroid therapy for fetal lung maturation in preterm delivery - one of the most evidence-backed interventions in perinatology. Topically, it is one of the most potent steroids available for dermatological use. Its lack of mineralocorticoid activity makes it unsuitable as monotherapy for adrenal insufficiency, but ideal when pure anti-inflammatory/immunosuppressive effects are needed.

It used with clotramozol.?

Finding Sources

Reading File

Excellent - rich information from multiple textbooks. Here is a complete answer.

Betamethasone + Clotrimazole (Lotrisone)

Yes, betamethasone is combined with clotrimazole as a fixed-dose topical combination product, most commonly known by the brand name Lotrisone.

The Combination

Component	Role	Concentration
Clotrimazole	Antifungal (azole)	1%
Betamethasone dipropionate	Potent corticosteroid	0.05%

Available forms: Cream and lotion (topical only)

Rationale for Combining

The combination was introduced on the basis of providing more rapid symptomatic relief (itch, redness, scaling) than an antifungal alone - the betamethasone quickly suppresses inflammation and pruritus while clotrimazole eradicates the fungus.

Katzung's Basic & Clinical Pharmacology, 16th ed.

Clotrimazole - Mechanism of Action

Clotrimazole is an imidazole azole antifungal that works by:

Inhibiting fungal cytochrome P450 14alpha-demethylase
This blocks the conversion of lanosterol to ergosterol, the essential component of the fungal cell membrane
Without ergosterol, the fungal membrane becomes permeable and dysfunctional, leading to cell death

Indications for the Combination

Used for fungal skin infections where significant inflammation is also present:

Tinea pedis (athlete's foot) with inflammation
Tinea cruris (jock itch) with inflammation
Tinea corporis (ringworm) with inflammation
Angular cheilitis (clotrimazole 1% / betamethasone 0.05% cream applied twice daily for 1-2 weeks) - Goldman-Cecil Medicine
Chronic otitis externa - a mixture including clotrimazole cream 1% and betamethasone 0.05% filled into the ear canal is used for chronic inflammatory/fungal external ear disease - Cummings Otolaryngology

Important Warnings and Limitations

⚠️ Avoid in Tinea Corporis / Tinea Cruris Without Supervision

The textbooks are explicit about the risks:

"Combination products with a potent corticosteroid such as clotrimazole/betamethasone frequently produce widespread tinea and fungal folliculitis. Their use should be avoided."

Andrews' Diseases of the Skin, Clinical Dermatology

The problem is that the corticosteroid suppresses the local immune response, masking the clinical signs of infection (redness, scaling, raised border disappear) while the fungus continues to spread unchecked. This leads to:

Tinea incognita - atypical appearing, widespread tinea with altered/masked appearance because the steroid suppresses signs
Majocchi's granuloma - deep fungal folliculitis when topical steroids drive fungi into hair follicles
Fungal folliculitis - widespread spread of dermatophytes

Other Important Warnings

Not for face, groin, or axillae in most cases (thin skin + high absorption = high risk of skin atrophy and systemic absorption of betamethasone)
Not for children < 12 years (augmented betamethasone; risk of adrenal suppression)
Not for nail infections (onychomycosis) - topical azoles do not penetrate the nail
Not for scalp tinea capitis - requires systemic antifungals (griseofulvin, terbinafine)
Maximum 2 weeks of use for tinea cruris and corporis
Red Book (AAP): "Avoid topical steroid combinations" - listed explicitly in the pediatric antifungal table

Bottom Line

Situation	Use Combination?
Inflammatory tinea pedis (athlete's foot)	Acceptable, short-term
Tinea corporis / tinea cruris	Avoid - risk of tinea incognita
Angular cheilitis	Yes, appropriate
Chronic otitis externa	Yes, in ENT practice
Children < 12 years	Avoid
Tinea capitis / onychomycosis	No - needs systemic therapy

The combination has a legitimate but narrow role. In general dermatology practice, plain antifungals (terbinafine, clotrimazole alone) are preferred for tinea infections because the added corticosteroid, despite providing faster symptom relief, can cause more harm than good by masking and spreading the infection.

This is a shared conversation. Sign in to Orris to start your own chat.